Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy

Urology

Volumn 64, Issue 5, 2004, Pages 955-958

  Rannikko, Antti ^a   Pétas, Anssi ^a   Taari, Kimmo ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CAPRILON; TRANEXAMIC ACID;

AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; TRANSURETHRAL RESECTION; TREATMENT INDICATION; TREATMENT OUTCOME; URINARY TRACT OBSTRUCTION;

AGED; ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; ORGAN SIZE; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC HYPERPLASIA; TIME FACTORS; TRANEXAMIC ACID; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 7944225422     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.07.008     Document Type: Article

References (30)

1. W.K. Mebust, H.L. Holtgrewe, A.T.K. Cockett Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients J Urol 141 1989 243 247
2. P.G. Borboroglu, C.J. Kane, J.F. Ward Immediate and postoperative complications of transurethral prostatectomy in the 1990s J Urol 162 1999 1307 1310
3. J.F. Donohue, H. Sharma, R. Abraham Transurethral prostate resection and bleeding a randomized, placebo controlled trial of the role of finasteride for decreasing operative blood loss J Urol 168 2002 2024 2026
4. J.A. Hagerty, J.D. Ginsberg, J.D. Harmon Pretreatment with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate Urology 55 2000 684 689
5. L. Sandfeldt, D.M. Bailey, R.G. Hahn Blood loss during transurethral resection of the prostate after 3 months of treatment with finasteride Urology 58 2001 972 976
6. J. Ekengren, R.G. Hahn Blood loss during transurethral resection of the prostate as measured by the Hemocue photometer Scand J Urol Nephrol 27 1993 501 507
7. J.D. Nielsen, J. Gram, A. Holm-Nielsen Bleeding and activation of coagulation during and after transurethral prostatectomy importance of the acute-phase response and prostate specific antigen? BJU Int 83 1999 990 995
8. C.R.W. Bell, P.J.A. Murdock, K.J. Pasi Thrombotic risk factors associated with transurethral prostatectomy BJU Int 83 1999 984 989
9. J.D. Nielsen, J. Gram, A. Fabrin Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate Br J Urol 80 1997 105 110
10. L. Andersson, I.M. Nilsson, S. Colleen Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA Ann NY Acad Sci 146 1968 642 658
11. J.D. Nielsen, J. Gram, A. Holm-Nielsen Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis Br J Urol 80 1997 889 893
12. P.M. Mannucci Hemostatic drugs N Engl J Med 339 1998 245 253
13. P.O. Madsen, A.E. Strauch The effect of aminocaproic acid on bleeding following transurethral prostatectomy J Urol 96 1966 255 256
14. C.J. Smart, A.R. Turnbull, J.D. Jenkins The use of frusemide and epsilon-amino-caproic-acid in transurethral prostatectomy Br J Urol 46 1974 521 525
15. R.B. Smith, P. Riach, J.J. Kaufman Epsilon aminocaproic acid and the control of post-prostatectomy bleeding a prospective double-blind study J Urol 131 1984 1093 1095
16. R. Sharifi, M. Lee, P. Ray Safety and efficacy of intravesical aminocaproic acid for bleeding after transurethral resection of prostate Urology 27 1986 214 219
17. B.L. Erstad Systemic hemostatic medications for reducing surgical blood loss Ann Pharmacother 35 2001 925 934
18. R.J. Porte, F.W. Leebeek Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery Drugs 62 2002 2193 2211
19. R.A. Miller, M.W. May, W.F. Hendry The prevention of secondary haemorrhage after prostatectomy the value of antifibrinolytic therapy Br J Urol 52 1980 26 28
20. R.G. Hahn, J.C. Ekengren Patterns of irrigating fluid absorption during transurethral resection of the prostate as indicated by ethanol J Urol 149 1993 502 506
21. E. Berntorp, C. Follrud, S. Lethagen No increased risk of venous thrombosis in women taking tranexamic acid Thromb Haemost 86 2001 714 715
22. M. Levi, M.E. Cromheecke, E. de Jong Pharmacological strategies to decrease excessive blood loss in cardiac surgery a meta-analysis of clinically relevant endpoints Lancet 354 1999 1940 1947
23. M.A. Ruel, F. Wang, M.E. Bourke Is tranexamic acid safe in patients undergoing coronary endarterectomy? Ann Thorac Surg 71 2001 1508 1511
24. D.W. Kaufman, S. Shapiro Epidemiological assessment of drug-induced disease Lancet 356 2000 1339 1343
25. M.G. Ward, B. Richards Complications of antifibrinolysis therapy after prostatectomy Br J Urol 51 1979 211 212
26. A.P. Berger, W. Wirtenberger, J. Bektic Safer transurethral resection of the prostate coagulating intermittent cutting reduces hemostatic complications J Urol 171 2004 289 291
27. T. Kolmert, H. Norlen Transurethral resection of the prostate a review of 1111 cases Int Urol Nephrol 21 1989 47 55
28. K. Koshiba, S. Egawa, M. Ohori Does transurethral resection of the prostate pose a risk to life? 22-year outcome J Urol 153 1995 1506 1509
29. P.J. Puchner, M.I. Miller The effects of finasteride on hematuria associated with benign prostatic hyperplasia a preliminary report J Urol 154 1995 1779 1782
30. M. Verstraete Clinical application of inhibitors of fibrinolysis Drugs 29 1985 236 261